Literature DB >> 17911087

Proximal calciphylaxis treated with calcimimetic 'Cinacalcet'.

Ismail A Mohammed1, Vashisht Sekar, Abdullah J Bubtana, Sandip Mitra, Alastair J Hutchison.   

Abstract

Calciphylaxis is a rare condition affecting patients suffering from end-stage renal failure, characterised by cutaneous ischaemia and necrosis. The management of calciphylaxis is challenging owing to the lack of optimal medical therapy, although parathyroidectomy has shown some benefit. We present a case of severe proximal calciphylaxis treated with a small dose of the calcimimetic 'Cinacalcet'.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17911087     DOI： 10.1093/ndt/gfm676

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


  16 in total

1.  [Calciphylaxis. Pathogenesis and therapy].

Authors:  N-P Hoff; B Homey
Journal:  Hautarzt       Date:  2011-07       Impact factor: 0.751

Review 2.  Calciphylaxis: risk factors, diagnosis, and treatment.

Authors:  Sagar U Nigwekar; Daniela Kroshinsky; Rosalynn M Nazarian; Jeremy Goverman; Rajeev Malhotra; Vicki Ann Jackson; Mihir M Kamdar; David J R Steele; Ravi I Thadhani
Journal:  Am J Kidney Dis       Date:  2015-05-07       Impact factor: 8.860

3.  Clinically applicable antianginal agents suppress osteoblastic transformation of myogenic cells and heterotopic ossifications in mice.

Authors:  Ryuichiro Yamamoto; Masaki Matsushita; Hiroshi Kitoh; Akio Masuda; Mikako Ito; Takenobu Katagiri; Tatsushi Kawai; Naoki Ishiguro; Kinji Ohno
Journal:  J Bone Miner Metab       Date:  2012-08-24       Impact factor: 2.626

Review 4.  [Cutaneous calciphylaxis].

Authors:  U Wollina
Journal:  Hautarzt       Date:  2010-12       Impact factor: 0.751

5.  Fetuin-mineral complex reflects extraosseous calcification stress in CKD.

Authors:  Takayuki Hamano; Isao Matsui; Satoshi Mikami; Kodo Tomida; Naohiko Fujii; Enyu Imai; Hiromi Rakugi; Yoshitaka Isaka
Journal:  J Am Soc Nephrol       Date:  2010-10-14       Impact factor: 10.121

6.  Sodium thiosulfate therapy for calcific uremic arteriolopathy.

Authors:  Sagar U Nigwekar; Steven M Brunelli; Debra Meade; Weiling Wang; Jeffrey Hymes; Eduardo Lacson
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-21       Impact factor: 8.237

7.  Nonuremic calciphylaxis precipitated by teriparatide [rhPTH(1-34)] therapy in the setting of chronic warfarin and glucocorticoid treatment.

Authors:  E K Spanakis; D E Sellmeyer
Journal:  Osteoporos Int       Date:  2013-11-29       Impact factor: 4.507

Review 8.  Novel regulatory aspects of the extracellular Ca2+-sensing receptor, CaR.

Authors:  Daniela Riccardi; Brenda A Finney; William J Wilkinson; Paul J Kemp
Journal:  Pflugers Arch       Date:  2009-05-30       Impact factor: 3.657

Review 9.  Cutaneous manifestations of ESRD.

Authors:  Timur A Galperin; Antonia J Cronin; Kieron S Leslie
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 8.237

10.  Calciphylaxis following kidney transplantation: a case report.

Authors:  Rajesh Hanvesakul; Michael A Silva; Rahul Hejmadi; Steve Mellor; Andrew R Ready; Paul Cockwell; Nicholas Inston
Journal:  J Med Case Rep       Date:  2009-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.